Literature DB >> 15865090

Feasibility of sentinel node concept in gastric carcinoma: clinicopathological analysis of gastric cancer with solitary lymph node metastases.

S P Moenig1, T Luebke, S E Baldus, W Schroeder, E Bollschweiler, P M Schneider, A H Hoelscher.   

Abstract

BACKGROUND: The feasibility and diagnostic reliability of sentinel lymph node biopsy of gastric carcinoma are still unclear and controversial. PATIENTS AND METHODS: To assess the applicability of the sentinel node concept to gastric carcinoma, we retrospectively analyzed the location of metastatic lymph nodes in patients with only one or two lymph node metastases.
RESULTS: A total of 135 patients, who underwent gastrectomy with D2 lymphadenectomy for primary gastric adenocarcinoma between 1997 and 2001, were enrolled in this study. An average of 39 lymph nodes were resected and analyzed for each patient. Of the 135 patients, 88 (65%) were subtyped as pN+ (with lymph node metastasis); of the latter, 15 cases (pT1-3; 17% of N+ cases) showed one or two lymph node metastases. In 14 (93%) of these patients, lymph nodes directly adjacent to the primary tumor were involved. Skip metastases were only seen in one patient with cardia carcinoma and lymph node involvement of compartment II (left gastric artery).
CONCLUSION: In patients with gastric carcinoma, especially in early stage carcinoma, the phenomenon of skip metastasis is infrequent. Therefore, the sentinel node concept may be feasible in gastric cancer.

Entities:  

Mesh:

Year:  2005        PMID: 15865090

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Skip lymph node metastasis in gastric cancer: is it skipping or skipped?

Authors:  Yoon Young Choi; Ji Yeong An; Ali Guner; Dae Ryong Kang; In Cho; In Gyu Kwon; Hyun Beak Shin; Woo Jin Hyung; Sung Hoon Noh
Journal:  Gastric Cancer       Date:  2015-02-24       Impact factor: 7.370

2.  A novel insight of sentinel lymph node concept based on 1-3 positive nodes in patients with pT1-2 gastric cancer.

Authors:  Baojun Huang; Zhenning Wang; Zhe Sun; Bo Zhao; Huimian Xu
Journal:  BMC Cancer       Date:  2011-01-17       Impact factor: 4.430

3.  The clinical significance and risk factors of solitary lymph node metastasis in gastric cancer.

Authors:  Min Ma; Shi Chen; Bao-yan Zhu; Bai-Wei Zhao; Hua-She Wang; Jun Xiang; Xiao-Bin Wu; Yi-Jia Lin; Zhi-Wei Zhou; Jun-Sheng Peng; Ying-Bo Chen
Journal:  PLoS One       Date:  2015-01-29       Impact factor: 3.240

Review 4.  Prognostic Significance of Solitary Lymphnode Metastasis and Micrometastasis in Gastric Cancer.

Authors:  Konstantinos D Mpallas; Vasileios I Lagopoulos; Apostolos G Kamparoudis
Journal:  Front Surg       Date:  2018-10-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.